Hyperangulated vs Macintosh Blades for Intubation With Videolaryngoscopy in ICU (INVIBLADE)

March 20, 2024 updated by: Manuel Taboada Muñiz, Hospital Clinico Universitario de Santiago

A Randomized Comparison Between the Hyperangulated vs. Macintosh Blades for First-attempt Intubation Success With Videolaryngoscopy in ICU Patients.

Tracheal intubation in the intensive care unit (ICU) is associated with high incidence of difficult intubation and complications. Videolaryngoscopes (VLs) devices have been proposed to improve airway management, and the use of VLs are recommended as first-line or after a first-attempt failure using direct laryngoscopy in ICU airway management algorithms. Although until relatively few years ago there were doubts about whether videolaryngoscopes had advantages over direct laryngoscopy for endotracheal intubation (ETI) in critically ill patients, two recent studies (DEVICE (1), INTUBATE (2)), and a Cochrane review (3) have confirmed that videolaryn should be used?, and what is the best blade? . There are two types of blades commonly used with videolaryngoscopes: the "Macintosh" blade with a slight curvature, and hyperangulated blades. The "Macintosh" blades have a lower angle of vision, but they have the advantage of being similar to the blades commonly used in direct laryngoscopy, making them easy to use for the person performing the ETI. Hyperangulated blades have a greater angle of vision, improving glottic visualization, especially in patients with an anterior glottis. However, the need to overcome this angulation could potentially hinder the passage of the endotracheal tube to the vocal cords. It is unknown if either blade has any advantage for intubating critically ill patients.

Study Overview

Detailed Description

The purpose of this prospective multicenter randomized study is to compare successful intubation on the first attempt with the Macintosh videolaryngoscope vs the hyperangulated videolaryngoscope during tracheal intubation in ICU patients.The hypothesis of the study is that tracheal intubation using the hyperangulated videolaryngoscope will improve the frequency of successful intubation on the first attempt in ICU patients requiring intubation in the intensive care unit.

Study Type

Interventional

Enrollment (Estimated)

1036

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • A Coruña, Spain
      • Albacete, Spain
        • Hospital General de Albacete
        • Contact:
          • Luisa María Charco
      • Barcelona, Spain
        • Hospital de la Santa Creu i Sant Pau, Barcelona
        • Contact:
          • Marta Giné
      • Cáceres, Spain
      • Denia, Spain
        • Hospital de Denia
        • Contact:
          • Marta Carrió
      • Elche, Spain
        • Hospital General Universitario de Eche
        • Contact:
          • Ana Pérez
      • Gijón, Spain
        • Hospital Universitario de Cabueñes, Gijón
        • Contact:
          • Rosaura María Santamarina
      • Granada, Spain
        • Hospital Virgen de las Nieves, Granada
        • Contact:
          • Jose Luis Aguilera
      • Las Palmas De Gran Canaria, Spain
        • Hospital Universitario de Gran Canaria Doctor Negrín
        • Contact:
          • Angel Becerra
      • León, Spain
        • Complejo Asistencial Universitario de Leon
        • Contact:
          • Inmaculada Fernández
      • Lugo, Spain
        • Hospital Universitario Lucus Augusti, Lugo
        • Contact:
          • María Bermúdez
      • Madrid, Spain
        • Hospital Universitario La Paz, Madrid
        • Contact:
          • Irene Vallejo
      • Madrid, Spain
        • Hospital Universitario La Princesa
        • Contact:
          • Fernando Ramasco
      • Madrid, Spain
        • Hospital Gregorio Marañón, Madrid
        • Contact:
          • Mercedes Power
      • Madrid, Spain
        • Hospital Universitario 12 de Octubre, Madrid
        • Contact:
          • Raquel García
      • Majadahonda, Spain
        • Hospital Universitario Puerta de Hierro, Majadahonda
        • Contact:
          • Sara Del Valle
      • Móstoles, Spain
        • Hospital Universitario de Móstoles
        • Contact:
          • Raquel Fernández
      • Ourense, Spain
        • Complexo Hospitalario Universitario de Ourense
        • Contact:
          • María Concepción Alonso
      • Oviedo, Spain
        • Hospital Universitario Central de Asturias (HUCA), Oviedo
        • Contact:
          • María Cristina Iglesias
      • Pamplona, Spain
        • Clinica Universidad de Navarra, Pamplona
        • Contact:
          • Marc Vives
      • Pontevedra, Spain
        • Complexo Hospitalario Universitario de Pontevedra
        • Contact:
          • Marina Varela
      • San Sebastián, Spain
        • Hospital Universitario Donostia, San Sebastián
        • Contact:
          • Anxo Rubín
      • Santander, Spain
        • Hospital Universitario Marqués de Valdecilla, Santander
        • Contact:
          • Mónica Williams
      • Segovia, Spain
        • Complejo Asistencial de Segovia
        • Contact:
          • Francisco Javier García
      • Valencia, Spain
        • Hospital Clínico Universitario de Valencia
        • Contact:
          • Sara Martínez
      • Valencia, Spain
        • Hospital Universitario La Fe de Valencia
        • Contact:
          • Azucena Pajares
      • Vigo, Spain
        • Complexo Hospitalario Universitario Álvaro Cunqueiro de Vigo
        • Contact:
      • Vigo, Spain
        • Hospital Ribera Povisa Vigo
        • Contact:
          • Rafael Cabadas
    • A Coruña
      • Santiago de Compostela, A Coruña, Spain, 15866
        • University Clinical Hospital of Santiago de Compostela

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18 years or older.
  • Admitted to an Intensive Care Unit.
  • Need for tracheal intubation during the stay in the ICU.
  • The device to be used for intubation is a videolaryngoscope

Exclusion Criteria:

  • Pregnancy or lactation.
  • Emergent tracheal intubation that does not allow for the randomization of the procedure.
  • Need for tracheal intubation with a device other than the videolaryngoscope (fiberoptic bronchoscope, direct laryngoscopy, tracheostomy, etc.).
  • Tracheal intubation performed outside the ICU (Emergency Department, Hospital ward, etc.).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hyperangulated videolaryngoscope
Tracheal intubation facilitated by a hyperangulated videolaryngoscope
For patients assigned to the Hyperangulated videolaryngoscope Group, the operator will use a Hyperangulated video laryngoscope on the first laryngoscopy attempt.
Active Comparator: Macintosh videolaryngoscope
Tracheal intubation facilitated by a videolaryngoscope with a Macintosh type blade
For patients assigned to the Macintosh videolaryngoscope Group, the operator will use a Hyperangulated video laryngoscope on the first laryngoscopy attempt.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in the first attempt intubation success rate (percentage)
Time Frame: During intubation (minutes)
The primary outcome is defined as placement of an endotracheal tube in the trachea with a single insertion of a videolaryngoscope blade into the mouth and either a single insertion of an endotracheal tube into the mouth or a single insertion of a bougie into the mouth followed by a single insertion of an endotracheal tube over the bougie into the mouth.
During intubation (minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in the overall success rate
Time Frame: During intubation (minutes)
To compare the difference overall success rate (percentage) with the two (hyperangulated vs Macintosh blades) videolaryngoscopes
During intubation (minutes)
Number of intubation attempts
Time Frame: During intubation (minutes)
To compare number of intubations attempts with the two (hyperangulated vs Macintosh blades) videolaryngoscopes
During intubation (minutes)
Modified Cormack-Lehane grade of glottic view
Time Frame: During intubation (minutes)

To compare Cormack-Lehane grade of glottic view with the two (hyperangulated vs Macintosh blades) videolaryngoscopes.

Modified Cormack-Lehane grade of glottic view is defined as:

Grade I: full view of the glottis Grade IIa: partial view of the glottis Grade IIb: arytenoid or posterior part of the vocal cords just visible Grade III: only epiglottis visible Grade IV: neither glottis nor epiglottis visible Cormack-Lehane grade of glottic view

During intubation (minutes)
Diference in the incidence of "easy intubation"
Time Frame: During intubation (minutes)
To compare the difference in the incidence of "easy intubation" defined as a patient with Cormack-Lehane I-II glottic view and intubation on the first attempt.
During intubation (minutes)
Duration of tracheal intubation
Time Frame: Duration of procedure (minutes)
To compare the interval (in seconds) between the first insertion of a videolaryngoscope blade into the mouth and the final placement of an endotracheal tube in the trachea.
Duration of procedure (minutes)
Reason for unsuccessful intubation on the first attempt
Time Frame: Duration of procedure (minutes)

Causes of unsuccessful intubation on the first attempt:

  • Limited visibility of the larynx
  • Difficulty in properly inserting the endotracheal tube
  • Challenges in cannulating the trachea with a bougie
  • Interruption of the attempt due to changes in the patient's condition (such as deteriorating hypoxemia, hypotension, bradycardia, vomiting, or bleeding)
  • Technical malfunctions with the laryngoscope equipment (such as battery issues, light source malfunction, camera problems, or screen issues)
  • Other factors
Duration of procedure (minutes)
Number of videolaryngoscopy attempts
Time Frame: Duration of procedure (minutes)
To compare the number of videolaryngoscope attempts neccesary to successfull tracheal intubation
Duration of procedure (minutes)
Number of attempts to cannulate the trachea with a bougie or an endotracheal tube
Time Frame: Duration of procedure (minutes)
To compare the number of attempts to cannulate the trachea with a bougie or an endotracheal tube
Duration of procedure (minutes)
Operator-assessed difficulty of intubation
Time Frame: Duration of procedure (minutes)

To compare operator-assessed subjective difficulty of intubation:

  • without difficulty
  • mild difficulty
  • moderate difficulty
  • severe difficulty
Duration of procedure (minutes)
Need for additional airway equipment
Time Frame: Duration of procedure (minutes)
Airway equipment: bougie, stylet, other videolaryngoscope, others
Duration of procedure (minutes)
Need to change the device for intubation
Time Frame: Duration of procedure (minutes)
Need to replace by another videolaryngoscope, a different angled blade, requirement for a fiberoptic bronchoscope...).
Duration of procedure (minutes)
Complications of tracheal intubation
Time Frame: Duration of procedure (minutes)

Complications:

  • Hypoxemia (lowest oxygen saturation measured by pulse oximetry 80%-90%)
  • Severe hypoxemia (lowest oxygen saturation measured by pulse oximetry < 80%)
  • Hypotension (systolic blood pressure between 80-65 mm Hg)
  • Severe hypotension (systolic blood pressure < 65 mm Hg)
  • Pulmonary aspiration
  • Esophageal intubation
  • Dental injuries
  • Airway injuries
  • Others
Duration of procedure (minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Manuel Taboada, Ph.D., University Clinical Hospital of Santiago de Compostela

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

May 1, 2024

Study Completion (Estimated)

May 30, 2024

Study Registration Dates

First Submitted

March 14, 2024

First Submitted That Met QC Criteria

March 20, 2024

First Posted (Actual)

March 21, 2024

Study Record Updates

Last Update Posted (Actual)

March 21, 2024

Last Update Submitted That Met QC Criteria

March 20, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified participant data How to access data: Requests must be sent to manutabo@yahoo.es When available: With publication Additional Information Who can access the data: Researchers whose proposed use of the data has been approved Types of analyses: For scientific purpose Mechanisms of data availability: With investigator support

IPD Sharing Time Frame

When available: With publication

IPD Sharing Access Criteria

Researchers whose proposed use of the data has been approved Types of analyses: For scientific purpose

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubation

Clinical Trials on Hyperangulated blade videolaryngoscope

3
Subscribe